FOXO Technologies Inc. (FOXO) NYSE MKT LLC
$0.27 (0.01) (-3.68%)
Market Cap: $2.48M
As of 04/19/24 04:00 PM EDT. Market closed.
FOXO Technologies Inc. (FOXO)
NYSE MKT LLC
$0.27
(0.01) (-3.68%)
Market Cap: $2.48M
As of 04/19/24 04:00 PM EDT. Market closed.
formerly yousurance and life epigenetics. foxo bioscience is transforming the global longevity insurance industry with a next-generation underwriting protocol and consumer engagement platform based on epigenetic technology and insights. we also offer leading supervised machine learning and artificial intelligence technologies to identify epigenetic biomarkers that measure current states of ... read more
formerly yousurance and life epigenetics. foxo bioscience is transforming the global longevity insurance industry with a next-generation underwriting protocol and consumer engagement platform based on epigenetic technology and insights. we also offer leading supervised machine learning and artificial intelligence technologies to identify epigenetic biomarkers that measure current states of health and aging. read less
Open in: 
Open in:
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| WARD MARTIN CHRISTOPHER | Interim CFO | Feb 06, 2024 | Sale | $0.42 | 250,000 | 105,000 | 0 | Feb 07, 2024, 03:07 PM |
| WHITE MARK BRIAN | Interim CEO | Feb 06, 2024 | Sale | $0.42 | 250,000 | 105,000 | 0 | Feb 07, 2024, 03:07 PM |
| Dowling Vincent J. Jr | 10% Owner | Jul 14, 2023 | Sale | $0.16 | 3,000 | 491 | 4,647,405 | Jul 18, 2023, 03:06 PM |
| Owner | Relationship | Date | Value($) |
| WARD MARTIN CHRISTOPHER | Interim CFO | 02/06/2024 | 105,000 |
| WHITE MARK BRIAN | Interim CEO | 02/06/2024 | 105,000 |
| Dowling Vincent J. Jr | 10% Owner | 07/14/2023 | 491 |
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 24,864 | 0% | New | Other |